Lord, Abbett & Co. LLC Pacific Biosciences Of California, Inc. Transaction History

Lord, Abbett & Co. LLC

$31.6 Billion
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 07, 2024	SELL	$5.97 - $10.36 $7.3 Million - $12.7 Million	-1,222,921 Reduced 33.36%	2,442,956 $24 Million
Q4 2023 Feb 12, 2024	SELL	$5.97 - $10.36 $7.3 Million - $12.7 Million	-1,222,921 Reduced 33.36%	2,442,956 $24 Million
Q3 2023 Oct 07, 2024	SELL	$8.23 - $13.93 $148,049 - $250,586	-17,989 Reduced 0.49%	3,665,877 $30.6 Million
Q3 2023 Nov 13, 2023	SELL	$8.23 - $13.93 $148,049 - $250,586	-17,989 Reduced 0.49%	3,665,877 $30.6 Million
Q2 2023 Oct 07, 2024	BUY	$9.97 - $14.05 $2.51 Million - $3.54 Million	251,862 Added 7.34%	3,683,866 $49 Million
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $2.51 Million - $3.54 Million	251,862 Added 7.34%	3,683,866 $49 Million
Q1 2023 Oct 07, 2024	SELL	$7.94 - $12.02 $6.19 Million - $9.38 Million	-780,131 Reduced 18.52%	3,432,004 $39.7 Million
Q1 2023 May 12, 2023	SELL	$7.94 - $12.02 $6.19 Million - $9.38 Million	-780,131 Reduced 18.52%	3,432,004 $39.7 Million
Q4 2022 Oct 07, 2024	BUY	$5.67 - $11.2 $23.9 Million - $47.2 Million	4,212,135 New	4,212,135 $34.5 Million
Q4 2022 Feb 10, 2023	BUY	$5.67 - $11.2 $23.9 Million - $47.2 Million	4,212,135 New	4,212,135 $34.5 Million
Q2 2021 Aug 11, 2021	SELL	$22.3 - $36.02 $22.7 Million - $36.7 Million	-1,019,453 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$26.38 - $51.15 $31.4 Million - $60.9 Million	-1,190,872 Reduced 53.88%	1,019,453 $34 Million
Q4 2020 Feb 09, 2021	SELL	$10.5 - $28.5 $5.49 Million - $14.9 Million	-522,875 Reduced 19.13%	2,210,325 $57.3 Million
Q3 2020 Nov 12, 2020	BUY	$3.61 - $9.87 $9.87 Million - $27 Million	2,733,200 New	2,733,200 $27 Million
Q4 2017 Feb 14, 2018	SELL	$2.59 - $5.44 $2.11 Million - $4.43 Million	-814,484 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.2 - $5.57 $708,713 - $1.23 Million	221,473 Added 37.35%	814,484 $4.28 Million
Q2 2017 Aug 14, 2017	BUY	N/A	593,011	593,011 $2.11 Million

Others Institutions Holding PACB

# of Institutions

259

Shares Held

256M

Call Options Held

3.05M

Put Options Held

1.71M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

36M
Shares

$55.5 Million
0.58% of portfolio
Black Rock Inc. New York, NY

23.6M
Shares

$36.4 Million
0.0% of portfolio
Madrone Advisors, LLC Menlo Park, CA

23.4M
Shares

$36 Million
8.16% of portfolio
Edmond De Rothschild Holding S.A. Chambesy, V8

21.3M
Shares

$32.9 Million
0.68% of portfolio
Softbank Group Corp Minato Ku Tokyo, M0

20.5M
Shares

$31.5 Million
0.17% of portfolio

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $346M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account